← Leaderboards
Andrew G. Bostom
Rhode Island Hospital (Providence, Ri)
$29,640,468
Attributed
$29,640,468
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $5M · FY2005–11$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$29,640,468 · 3
By mechanism
U01$29,006,680 · 1
R01$560,060 · 1
P20$73,728 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Homocysteine”
- Hong Wang · Baylor College Of Medicine$19,084,090
- Philip A Wolf · Boston University Medical Campus$16,711,461
- Laurence N. Kolonel · University Of Hawaii At Manoa$14,215,517
- Suresh C Tyagi · University Of Louisville$13,100,083
- Shenghan Lai · University Of Miami Coral Gables$10,742,741
- Gerald S Berenson · Tulane University Of Louisiana$10,635,618
Research focus
HomocysteineCreatinineClinical TrialsKidney TransplantationVitamin B6FundingKidney FailureAffectHeartRandomizedDesignArteriosclerotic Cardiovascular DiseaseAlbuminuriaCardiovascular Disorder RiskCardiovascular DiseasesDiabetes MellitusCoronaryChronicAncillary StudyCognitiveCognitive FunctionChronic Kidney InsufficiencyDialysis ProcedureCerebrovascular
Grant awards (17)
Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial$900,000
U01 · FY2011 · DK · contact PI
A RANDOMIZED, PLACEBO-COTROLLED PILOT STUDY OF THE EFFECTS OF ONCE$73,728
P20 · FY2011 · RR · contact PI
Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial$142,772
U01 · FY2010 · DK · contact PI
Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial$1
U01 · FY2010 · DK · contact PI
Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial$4,000,000
U01 · FY2009 · DK · contact PI
Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial$4,000,000
U01 · FY2008 · DK · contact PI
Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial$963,907
U01 · FY2008 · DK · contact PI
Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial$4,000,000
U01 · FY2007 · DK · contact PI
A Randomized, Controlled Trial for Homocysteine$600,000
U01 · FY2007 · DK · contact PI
A Randomized, Controlled Trial for Homocysteine$400,000
U01 · FY2006 · DK · contact PI
A Randomized, Controlled Trial for Homocysteine$3,700,000
U01 · FY2005 · DK
A Randomized, Controlled Trial for Homocysteine$3,400,000
U01 · FY2004 · DK
A Randomized, Controlled Trial for Homocysteine$3,200,000
U01 · FY2003 · DK
A Randomized, Controlled Trial for Homocysteine$3,200,000
U01 · FY2002 · DK
Serum Total Homocysteine and C-Reactive Protein as Pred$281,700
R01 · FY2002 · HL
A Randomized, Controlled Trial for Homocysteine$500,000
U01 · FY2001 · DK
Serum Total Homocysteine and C-Reactive Protein as Pred$278,360
R01 · FY2001 · HL